SoftBank's Twin Dilemma: A Record Quarter at Arm Can't Mask the $10 Billion Question
Published on 08/01/2026 at 17:14 | Redaktion boerse-global.de
The arithmetic of SoftBank Group's stock this week tells a story of two competing realities. On one side sits Arm Holdings, the British chip designer in which SoftBank holds roughly 90 percent, delivering blowout quarterly numbers. On the other sits a $10 billion loan negotiation, a looming $40 billion repayment deadline, and a global sell-off in precisely the kind of assets that make up the Japanese conglomerate's portfolio.
By Friday's close, SoftBank shares had settled at EUR 27.10, a modest 0.74 percent gain on the day. The weekly scoreboard, however, was far less forgiving: a 6.71 percent decline. Stretch the lens to a month and the picture darkens further, with the stock down 13.56 percent. The relative strength index at 38.7 suggests the equity is drifting toward oversold territory — a condition that sometimes precedes stabilization, though it guarantees nothing.
Arm's Numbers Impress, but the Market Looks Ahead
The catalyst for the week's turbulence originated in Cambridge, not Tokyo. Arm Holdings posted first-quarter results for fiscal 2027 that comfortably cleared analyst forecasts. Adjusted earnings per share came in at USD 0.45 against expectations of USD 0.40. Revenue climbed 22 percent year over year to USD 1.29 billion, edging past the USD 1.26 billion consensus. The standout performer was the licensing business tied to data centers, where revenue more than doubled.
Yet investors chose to fixate on Arm's forward guidance rather than its rearview mirror. The question of whether current AI valuations remain defensible hung over the session, muting what should have been an unequivocal positive for SoftBank's largest asset.
Just as investors scrutinise SoftBank's risk exposure, UK employers face their own compliance obligations — and many underestimate the gaps in their workplace safety documentation. A free toolkit with 41 ready-to-use templates and checklists helps you identify and address those gaps before they become costly problems. Download the free Risk Assessment Toolkit
A Margin Loan That Carries the Weight of the Balance Sheet
Complicating matters is a financing puzzle that has moved to the center of the investment thesis. SoftBank has resumed talks with a consortium of banks over a USD 10 billion margin loan secured against its stake in OpenAI. An earlier attempt collapsed, with lenders balking at the difficulty of valuing a private company. This time around, SoftBank is offering a repayment guarantee — if the collateral loses value, the conglomerate itself will make good on the shortfall.
The clock adds urgency. By March 2027, SoftBank must repay a USD 40 billion bridge loan that originally funded its OpenAI investment. Without a successful refinancing, that deadline looms with no visible fallback. Goldman Sachs, JPMorgan Chase and Mizuho Financial Group are all named as potential lenders.
The stakes are compounded by SoftBank's sensitivity to Japanese monetary policy. The Bank of Japan concluded its July 31, 2026 meeting with an 8-to-1 vote to hold the policy rate at 1.0 percent. Board member Hajime Takata dissented, calling for a 25-basis-point hike. With the central bank signaling that inflation is converging on its 2 percent target, further tightening remains on the table — a meaningful risk for a highly leveraged investment company whose balance sheet is exposed to yen-dollar dynamics.
The Quality of the Book Gains
A third thread runs through the debate: the composition of SoftBank's reported profits. The conglomerate booked a record gain of roughly JPY 5.02 trillion for the past fiscal year, but a substantial portion hinges on the mark-to-market value of its OpenAI stake — an asset inherently harder to pin down than listed chip revenue.
Chief Financial Officer Yoshimitsu Goto has pushed back against the perception that SoftBank is merely a collection of paper gains. He has repositioned Arm as the group's true core, emphasizing the company's evolution from pure licensing model to direct chip designer. The messaging aims to give investors a more tangible valuation anchor than a portfolio of unrealized positions.
A Sector-Wide Squall
The broader market context has done SoftBank no favors. Late July brought a sector-wide rout that swept through chip and AI names, erasing more than USD 1 trillion in market value from the semiconductor industry in a single week. SoftBank lost nearly 7 percent in one session alone. One strategist characterized the sell-off as another pullback in US tech and AI winners driven by concerns over excessive capital expenditure — not a structural break in AI demand.
The volatility metrics underline the fragility. SoftBank's annualized 30-day volatility stands at 73.01 percent, a figure that signals how sharply the stock can react to negative headlines on either financing or AI sentiment.
Two Scenarios, One Calendar
The near-term direction hinges on whether the loan talks conclude — and on what terms. A successful deal would give SoftBank breathing room ahead of the 2027 repayment. A second failure would leave the company approaching that deadline without visible alternatives. There is also a potential catalyst in the wings: OpenAI confidentially filed for a US initial public offering in June. A successful listing would make valuing SoftBank's stake far easier for lenders and could enhance the collateral behind the loan. Reports, however, suggest the IPO timeline may slip.
The next scheduled inflection point arrives on August 6, 2026, when SoftBank reports first-quarter results for the fiscal year ending March 2027. Management will likely face questions on both the status of the credit negotiations and the broader AI investment strategy — the two forces that have done the most to move the stock in recent weeks.
For now, the market is weighing two competing narratives: SoftBank as a leveraged bet on OpenAI's private valuation, or SoftBank as a chip powerhouse anchored by Arm's public earnings. The share price has yet to decide which one wins.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
